Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)

NCT00098839 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

134

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Childhood Acute Lymphoblastic Leukemia

Interventions

DRUG: L-asparaginase
DRUG: doxorubicin hydrochloride
DRUG: therapeutic hydrocortisone
DRUG: vincristine sulfate
BIOLOGICAL: epratuzumab
DRUG: cytarabine
DRUG: prednisone
DRUG: pegaspargase
DRUG: dexrazoxane hydrochloride
DRUG: methotrexate
DRUG: etoposide
DRUG: cyclophosphamide
DRUG: leucovorin calcium
BIOLOGICAL: filgrastim

Sponsor

Children's Oncology Group

Collaborators

[object Object]